Concomitant treatment with lamivudine renders cladribine inactive by inhibition of its phosphorylation.
Chtioui
Haithem
H
Millius
Claudine
C
Lämmle
Bernhard
B
Lauterburg
Bernhard H
BH
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017338:Cladribine / Q000627:therapeutic use*; D004347:Drug Interactions; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010766:Phosphorylation; D017211:Treatment Failure
D000970:Antineoplastic Agents; D019259:Lamivudine; D017338:Cladribine